학술논문
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy
Document Type
Short Communication
Author
Othman, Jad; Tiong, Ing S.; O'Nions, Jenny; Dennis, Mike; Mokretar, Katya; Ivey, Adam; Austin, Michael; Latif, Anne-Louise; Amer, Mariam; Chan, Wei Yee; Crawley, Charles; Crolla, Francesca; Cross, Joe; Dang, Ray; Elliot, Johnathon; Fong, Chun Y.; Galli, Sofia; Gallipoli, Paolo; Hogan, Francesca; Kalkur, Pallavi; Khan, Anjum; Krishnamurthy, Pramila; Laurie, John; Loo, Sun; Marshall, Scott; Mehta, Priyanka; Murthy, Vidhya; Nagumantry, Sateesh; Pillai, Srinivas; Potter, Nicola; Sellar, Rob; Taylor, Tom; Zhao, Rui; Russell, Nigel H.; Wei, Andrew H.; Dillon, Richard
Source
In Blood August 2023
Subject
Language
ISSN
0006-4971